Johnson & Johnson MEDTECH — Currency translation/Other decreased by 336.0% to -$59.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 172.0%, from $82.00M to -$59.00M. Over 2 years (FY 2021 to FY 2025), MEDTECH — Currency translation/Other shows an upward trend with a 28.5% CAGR.
Significant fluctuations indicate high exposure to international markets and currency volatility.
Captures the impact of foreign exchange rate fluctuations on the valuation of goodwill and other assets within the MedTe...
Reported by multinational corporations with significant non-domestic operations.
jnj_segment_medtech_currency_translation_other| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$66.00M | -$5.00M | -$19.00M | -$46.00M | -$36.00M | $171.00M | $4.00M | $176.00M | -$87.00M | -$20.00M | $132.00M | -$181.00M | $82.00M | $230.00M | $0.00 | $25.00M | -$59.00M |
| QoQ Change | — | — | +92.4% | -280.0% | -142.1% | +21.7% | +575.0% | -97.7% | >999% | -149.4% | +77.0% | +760.0% | -237.1% | +145.3% | +180.5% | -100.0% | — | -336.0% |
| YoY Change | — | — | — | — | — | +45.5% | >999% | +108.7% | — | -150.9% | -600.0% | — | -202.8% | +194.3% | >999% | -100.0% | +113.8% | -172.0% |